Implementing a Robust Change Control Program - Key Elements for Process and Documentation Compliance
Regulatory agencies require pharmaceutical and medical device companies to have a systematic approach to managing all changes made to their facilities, products, and/or quality systems. Given the fact that changes are inevitable, it is essential that companies have a compliant and effective change control program to ensure that no unnecessary or cGMP-related changes occur. Documentation of change control, including document authoring, updates, archiving, and related activities is not only a critical component of this exercise but is also mandated by all global health authorities.
This course will discuss regulatory expectations from the FDA, EU, and ICH perspectives, review all the required components of a thorough change control program, and discuss the elements regarding the successful management of an effective change control system.
At the completion of this course, attendees will be able to:
- Interpret the requirements of the FDA, EU, and ICH guidelines regarding compliant Change control records.
- Explain all the required components of a thorough Change control record
- Recognize the critical aspects of documentation and document control
- Apply all the elements of effective Change control management
This course will be of benefit to anyone working in manufacturing, facilities, or quality environment on a global or domestic scale who is involved in change control or quality systems. This includes personnel in:
- Production
- IT
- Facilities and Engineering
- Validation
- Quality Control
- Quality Assurance
- Regulatory Affairs
Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.
Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.
Upcoming Webinars
By Margie Faulk
Date: April 24, 2024
By Harold Levy
Date: April 25, 2024
By Dr. Susan Strauss
Date: April 26, 2024
By Marcia Zidle
Date: April 29, 2024
By Carolyn Troiano
Date: April 29, 2024
By Justin Muscolino
Date: April 29, 2024
By Ben Currie
Date: May 1, 2024
By Audrey Halpern
Date: May 1, 2024
By Mary Gormandy White
Date: May 1, 2024
By Pete Tosh
Date: May 1, 2024
By Diane L. Dee
Date: May 2, 2024
By Jeff Kasoff
Date: May 2, 2024
By Carolyn Troiano
Date: May 3, 2024
By Paul J. Cline
Date: May 3, 2024
By Richard E Cascarino
Date: May 6, 2024
By Edwin Waldbusser
Date: May 7, 2024
By Beverly Beuermann-King
Date: May 7, 2024
By Marcia Zidle
Date: May 7, 2024
By William J. Rothwell
Date: May 7, 2024
By Bob McKenzie
Date: May 8, 2024
By Patrick Haggerty
Date: May 9, 2024
By Margie Faulk
Recorded Session
By Miles Hutchinson
Recorded Session
By Deborah Covin Wilson
Recorded Session
By Donna K Olheiser
Recorded Session
By Catherine M. Mattice
Recorded Session
By Neil Malek
Recorded Session
By Deborah Covin Wilson
Recorded Session
By Ray Graber
Recorded Session
By Janette Levey Frisch
Recorded Session
By Paul J. Sanchez
Recorded Session
By Catherine M. Mattice
Recorded Session
By Danielle DeLucy
Recorded Session
By Lisa Marsden
Recorded Session
By E. Pete Lewis
Recorded Session
By Mike Thomas
Recorded Session
By Deborah Covin Wilson
Recorded Session
By Jeff Kasoff
Recorded Session
By Candace Curry Leuck
Recorded Session
By Loren Gelber
Recorded Session
By Rebecca Staton-Reinstein
Recorded Session
By Marcia Zidle
Recorded Session
By Paul R Hales
Recorded Session
By Paul J. Sanchez
Recorded Session
By Margie Faulk
Recorded Session
By Deborah Covin Wilson
Recorded Session
By Lisa Marsden
Recorded Session
By Michael D Haberman
Recorded Session
